@SMAresearch Profile picture

SMA Research

@SMAresearch

Spinal Muscular Atrophy scientific research news from around the world. Follow @smatrust for general SMA Trust information and fundraising updates.

Similar User
Cure SMA photo

@CureSMA

SMA News Today photo

@SMANewsToday

Spinal Muscular Atrophy UK photo

@SMA_UK_

TREAT-NMD photo

@TREAT_NMD

SMA-Europe photo

@SMAEurope

Dr Haiyan Zhou photo

@lab_zhou

Brunhilde Wirth photo

@BrunhildeWirth

Journal of Neuromuscular Diseases photo

@journal_nd

Pharmacy Research UK photo

@PharmResUK

Healthy Debate photo

@HealthyDebate

ENMC photo

@_ENMC

Action Duchenne photo

@ActionDuchenne

Cure SMA Foundation of India 🇮🇳 photo

@curesmaindia

ern euro_nmd photo

@euro_nmd

The National Centre for the 3Rs photo

@NC3Rs

Today is #UKSMAAwarenessDay! Spinal Muscular Atrophy is a rare, genetically inherited neuromuscular condition. Please retweet to help raise awareness of #SMA

Tweet Image 1

SMA Research Reposted

We are honoured to be supported and have the opportunity to work with @MDUK_News !

We're happy to announce we're funding Dr Bowerman @BowermanNMD at @KeeleUniversity to investigate whether combining a potential new #SMA drug with emerging genetic therapies for #SMA can lead to a more effective treatment. Read more here: qoo.ly/sav3e

Tweet Image 1


UK #SMA Research conference attendees, representing @NDCNOxford @EdinUniNeuro @neuroshef SMAReach @UCL_ICH @ryanezmunoz @ISTM_Keele @univofstandrews - Mostly all funded by @smatrust at some point!

Tweet Image 1

A day at #SITRAN, finding out what the UK #SMA laboratories are working on. Keynote delivered by Prof Azzouz on DNA damage in SMA.

Tweet Image 1

End-of-study results from Biogen's CHERISH trial demonstrate stabilisation or improvement in motor function in individuals with #SMA, where the natural history of the disease is a decline in motor function over time. bit.ly/2HPjJh0


#SMAEurope held its first international scientific congress on #SMA in Krakow, Poland 🎓. It was a huge success. Find out more from @drgroen : bit.ly/2sHBSts


SMA Research Reposted

20 days to go until SMA Europe's first Scientific & Clinical Congress 🎓on SMA! Although geared to researchers & clinicians, we will be reporting back. In the meantime, check out our programme! bit.ly/2xv8V5O


Scottish Medicines Consortium will be assessing #nusinersen for patients with SMA. We will be working with @SMASupportUK & @smatrust to provide a Patient Group Submission. #SMA


RT @amrc: Please read our statement on the Government's announcement of a new accelerated access pathway: bit.ly/2yrog8o #sma


RT @SMAEurope: 2 days left before abstract submisson deadline 4 our int. scientific Congress on #SMA. Get them in! ow.ly/Nh3A30g7NbQ


Roche provided a community statement on the SUNFISH clinical trial RG7916 for #SMA. Find out what it says here: ow.ly/Id3a30fVMoq


SMA Research Reposted

Great news! Early Bird registration 4 our #SMA Congress in Krakow extended until 27th Oct! Register quickly here: bit.ly/2yKUpo2


SMA Research Reposted

We expect an exiting meeting with top invited speakers, oral presentations from selected abstracts, posters, workshops, prizes. Do not miss!

Are you an #SMA researcher or clinician? Do not miss the 1st European SMA Congress in Krakow, Jan 2018. All details: ow.ly/O9p230f4e8k



AveXis 2 initiate pivotal trial for gene replacement product, AVXS-101, in #SMA Type 1 in the U.S. ow.ly/hGFc30fBnc4


SMA Research Reposted

3 days left for early bird registration 2 our #SMA conference in Krakow. Don't miss out! #smaresearch #SMAKrakow2018 bit.ly/2yKUpo2


Roche announces start of the 2nd part of the Phase 2 #SUNFISH clinical trials 4 Type 2/3 #SMA. Find out more: ow.ly/4Kgo30fenjT


SMA Research Reposted

I'm registered! Are you?

Are you an #SMA researcher or clinician? Do not miss the 1st European SMA Congress in Krakow, Jan 2018. All details: ow.ly/O9p230f4e8k



SMA Research Reposted

Follow @BowermanNMD 's lead and register 4 our first European Congress on #SMA ! We have a very exciting programme: bit.ly/2xv8V5O

I'm registered! Are you?



Loading...

Something went wrong.


Something went wrong.